Prostate Cancer Breakthrough
"Together in Discovery and Care" is the theme for the 19th Asia-Pacific Prostate Cancer Conference taking place in Brisbane from the 22-25 August 2018.
Prostate cancer is the most common cancer diagnosed in Australia and it’s the third most common cause of death from the disease.
The Prostate Cancer Foundation says the need for increased education, improved treatment options and sharing of knowledge on prostate cancer treatment has never been so important.
This year’s three-day Asia-Pacific Cancer Conference will present a world-class faculty of both Australian and International presenters, and streams in Clinical Urology, Translational Science, Nursing and Allied Health, to ensure the most contemporary information and research-validated findings are presented.
One of the eminent international speakers at the conference will be Dr Stacy Loeb, Assistant Professor of Urology and Population Health at New York University. Professor Loeb concedes that historically, Prostate-Specific-Antigen (PSA) testing has historically been the subject of much controversy. A high PSA reading from a blood test does not necessarily indicate the presence of cancer in the prostate gland but by the same token, a low reading may not mean the absence of the disease either.
Although it is certainly not the only methodology available today, Professor Loeb says exhaustive research indicates the pros of PSA testing far outweigh the cons.
Click on the image below to view the video:
In a recent interview, Kendra Overrall, the former State Manager of the Prostate Cancer Foundation of Australia outlined the work being done by the PCFA. She also introduced Alan White who at the time of this interview was an Ambassador for the Prostate Cancer Foundation of Australia. Alan not only spoke frankly about living with the disease but offered a valuable insight into the ways in which he has been able to support other sufferers.
Click below to view the video: